Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

INFLIFE:SV

29.92 EUR 0.08 0.27%

As of 10:18:00 ET on 03/26/2015.

Snapshot for Infond Life (INFLIFE)

Year To Date: +16.86% 3-Month: +17.54% 3-Year: +28.71% 52-Week Range: 19.57 - 31.21
1-Month: +3.06% 1-Year: +46.93% 5-Year: +18.55% Beta vs SBITOP: 0.41

Mutual Fund Chart for INFLIFE

No chart data available.
  • INFLIFE:SV 29.92
  • 1M
  • 1Y
Interactive INFLIFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for INFLIFE

Infond Life is an open-end investment fund incorporated in Slovenia. The Fund's objective is to invest primarily in companies from healthcare sector. The Fund's objective is capital appreciation.

Inception Date: 06-04-2007 Telephone: 386-2-229-2080
Managers: BARBARA GACNIK
Web Site: www.infond.si

Fundamentals for INFLIFE

NAV (on 2015-03-26) 29.92
Assets (M) (on 2015-03-26) 35.27
Fund Leveraged N
Minimum Investment 12.00
Minimum Subsequent Investment -

Dividends for INFLIFE

No dividends reported

Fees & Expenses for INFLIFE

Front Load 3.00
Back Load 0.00
Current Mgmt Fee 2.25
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 2.33

Top Fund Holdings for INFLIFE

Filing Date: 02/27/2015
Name Position Value % of Total
Novartis AG 19,372 1,722,712 5.250%
Pfizer Inc 51,591 1,581,613 4.820%
Roche Holding AG 5,791 1,361,763 4.150%
Johnson & Johnson 13,832 1,266,603 3.860%
Gilead Sciences Inc 12,454 1,151,756 3.510%
Merck & Co Inc 20,959 1,095,973 3.340%
UnitedHealth Group Inc 9,147 925,342 2.820%
Actavis plc 3,543 922,061 2.810%
Amgen Inc 6,475 912,217 2.780%
Bayer AG 6,881 905,654 2.760%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil